Categories Annual ReportsCorporate GovernanceDefault CalendarFeatured DocumentsPresentationsProxy Statements Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Title Supernus Announces Proposed Offering of $75 Million of Convertible Senior Secured Notes 2012 Annual Report Supernus Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Financial Results Supernus Announces Year-End and Fourth Quarter 2012 Earnings Conference Call and Webcast Supernus Launches Oxtellar XR(TM) in the United States Supernus Appoints Victor Vaughn as Senior Vice President of Sales Supernus Announces Pricing of Public Offering Supernus Announces Positive Phase IIb Results on SPN-810 and Decision to Advance to Late Stage Development Supernus Receives Three Years of Market Exclusivity for Oxtellar XR(TM) Supernus Pharmaceuticals Reports Third Quarter 2012 Financial Results Pagination First page « first Previous page ‹ previous … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 Next page next › Last page last »